You are here

Articles of interest


Project Data Sphere, LLC (PDS) is an independent, not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC), a group formed by President Bush in 2001 to look at the ways in which different organisations can come together to improve outcomes in cancer research that no individual group could do by itself. The data-sharing platform is one of the projects developed by the group.

Munro, Dan. "Big Pharma Opens New Chapter On Big Data Collaboration." Forbes, April 08, 2014.

In the course of one short week, no less than 3 different models have emerged for sharing big data in the pharmaceutical industry. The highest profile of these ‒ called Project Data Sphere (PDS here) ‒ was announced earlier today with the official opening of an online resource to share clinical trial data for use in cancer research.

Big Pharma spends billions of dollars each year researching, developing and testing new treatments for cancer. In the meantime, it’s also collecting millions of data points that figuratively sit on a shelf and collect dust once a clinical trial is complete. A consortium of Big Pharma companies and research organizations are attempting to give that raw data a second life by making it available to researchers on the new Project Data Sphere platform.


The CEO Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard, salutes SAS Institute for being ranked No.1 on FORTUNE magazine’s annual “100 Best Companies to Work For” list.


The Wistar Institute, an international leader in biomedical research with expertise in cancer research and vaccine development, was accredited in August 2008, with the CEO Cancer Gold Standard™ from the CEO Roundtable on Cancer, in recognition of its efforts to improve the health of employees and their families and reduce their risks of cancer.


Weldon, William C. "The CEO's Role in Fighting Cancer." Chief Executive, January 16, 2008.

Few actions in the tenure of a CEO are more personally rewarding than saving and improving human lives. It is one reason I am so proud to be part of a company like Johnson & Johnson, a leader in health care whose products and services touch the lives of over a billion people every day. It is also the reason I have been motivated to be part of the CEO Roundtable on Cancer.


"Tobacco Free Company a Big Hit." August 06, 2007.

Smoke breaks are now prohibited at one pharmaceutical research company at Research Triangle Park. Since going totally tobacco-free last month, Quintiles says its new policy has actually helped scores of employees put cigarettes out for good.

Ready, Tinker. "Can CEOs Cure Cancer?." Fast Company, July 24, 2007.

Big Pharma execs may not know more about the disease than the rest of us, but a group of them are using their power to fight it.

Johnson, Daniel T. "Companies Heed Bush's Call to Battle." Triangle Business Journal, July 13, 2007.

"When the former president calls to ask you something, you know that you're going to say yes," Ingram says with a laugh."

Murphy, Martin J. "Homage to Joel Siegel." The Oncologist, July 2007.

Joel Siegel, a celebrated American television personality, died on June 29, 2007 ... with his wife, Ena, and his son, Dylan, at his side. He would have been 64 years young a few days later. He died of metastatic cancer of the colon ... at diagnosis, nine years ago, he already had advanced disease.


Vollmer, Sabine. "Wellness Conquers Cancer." The News & Observer, December 07, 2006.

One by one, large Triangle employers are starting to urge their employees to eat more broccoli, start exercising and stop smoking.

Laws, Jerry. "Step Up to the CEO Cancer Gold Standard." Occupational Health & Safety, May 01, 2006.

The Gold Standard: It is a perfect name for a program I am thrilled to bring to your attention. Several close relatives and friends of mine have survived or lost their battles with cancer, and it's safe to say most readers can say the same or have undergone treatment themselves.